tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MNKD Stock Latest News

MannKind Corporation’s Phase 3 Study: A Potential Game-Changer for Nontuberculous Mycobacterial Infections
Company AnnouncementsMannKind Corporation’s Phase 3 Study: A Potential Game-Changer for Nontuberculous Mycobacterial Infections
20d ago
MNKD
MannKind price target raised to $15 from $12 at Oppenheimer
PremiumThe Fly
MannKind price target raised to $15 from $12 at Oppenheimer
23d ago
MNKD
Positive TETON-2 Study Results Drive Buy Rating and Price Target Increase for MannKind
PremiumRatings
Positive TETON-2 Study Results Drive Buy Rating and Price Target Increase for MannKind
26d ago
MNKD
MannKind price target raised to $11 from $9 at H.C. Wainwright
PremiumThe Fly
MannKind price target raised to $11 from $9 at H.C. Wainwright
26d ago
MNKD
UTHR
Unusually active option classes on open September 2nd
PremiumThe Fly
Unusually active option classes on open September 2nd
26d ago
AG
KR
MannKind’s Strategic Collaborations and Innovations Drive Buy Rating Amid Promising IPF Treatment Developments
PremiumRatingsMannKind’s Strategic Collaborations and Innovations Drive Buy Rating Amid Promising IPF Treatment Developments
26d ago
MNKD
Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
Premium
The Fly
Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
30d ago
AHL
SWX
MannKind Amends License Agreement with United Therapeutics
Premium
Company Announcements
MannKind Amends License Agreement with United Therapeutics
1M ago
8K
MNKD
MannKind, United Therapeutics expand collaboration for second inhaled therapy
PremiumThe Fly
MannKind, United Therapeutics expand collaboration for second inhaled therapy
1M ago
MNKD
UTHR
scPharmaceuticals downgraded to Hold from Buy at Maxim
PremiumThe Fly
scPharmaceuticals downgraded to Hold from Buy at Maxim
1M ago
MNKD
SCPH
MannKind price target raised to $8 from $7 at RBC Capital
PremiumThe Fly
MannKind price target raised to $8 from $7 at RBC Capital
1M ago
MNKD
SCPH
H.C. Wainwright positive on MannKind deal for scPharmaceuticals
PremiumThe Fly
H.C. Wainwright positive on MannKind deal for scPharmaceuticals
1M ago
MNKD
SCPH
H.C. Wainwrights positive on MannKind deal for scPharmaceuticals
PremiumThe FlyH.C. Wainwrights positive on MannKind deal for scPharmaceuticals
1M ago
MNKD
SCPH
Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz
Premium
The Fly
Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz
1M ago
S
KR
MannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value Creation
Premium
Ratings
MannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value Creation
1M ago
MNKD
MannKind’s Strategic Acquisition and Growth Prospects: A Buy Rating by Yun Zhong
PremiumRatings
MannKind’s Strategic Acquisition and Growth Prospects: A Buy Rating by Yun Zhong
1M ago
MNKD
MannKind Announces Acquisition of scPharmaceuticals
PremiumCompany Announcements
MannKind Announces Acquisition of scPharmaceuticals
1M ago
8K
MNKD
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
PremiumThe Fly
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
1M ago
MNKD
SCPH
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
PremiumThe Fly
MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash
1M ago
MNKD
SCPH
MannKind’s Growth Potential and Stability: Buy Rating Reinforced by Pipeline Progress and Strategic Catalysts
PremiumRatingsMannKind’s Growth Potential and Stability: Buy Rating Reinforced by Pipeline Progress and Strategic Catalysts
2M ago
MNKD
MannKind Corporation’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
MannKind Corporation’s Earnings Call Highlights Growth and Challenges
2M ago
MNKD
MannKind Corporation Reports Q2 2025 Financial Growth
Premium
Company Announcements
MannKind Corporation Reports Q2 2025 Financial Growth
2M ago
MNKD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >